You just read:

Dilaforette Signs Collaboration Agreement With Arabian Gulf University (Bahrain) for Phase 2 Clinical Development of sevuparin for Sickle Cell Disease

News provided by

Dilaforette AB

16 Feb, 2016, 07:00 GMT